Giant gastrointestinal stromal tumor, associated with esophageal hiatus hernia by Miyauchi, Takayuki et al.
INTRODUCTION
Gastrointestinal stromal tumor (GIST) constitutes
the largest category of primary non-epithelial neo-
plasms of the stomach and the intestine. They arise
from cells, located in the wall of the gastrointesti-
nal organs and show marked variability in their
differentiation pathways (1). In this report, we will
report the case of a woman with giant GIST origi-
nating from the stomach wall, and associated with
an esophageal hiatus hernia. We also report the
beneficial effect of a self-expandable metallic stent for
palliative treatment against stricture due to non-curable
GIST. No autopsy was performed.
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Abstract : An 85-year-old woman was admitted to our hospital because of vomiting. An up-
per gastrointestinal series what showed a large esophageal hiatus hernia, suggesting an
association with extrinsic pressure in the middle portion of the stomach. An upper gastro-
intestinal endoscopic examination showed severe esophagitis and a prominent narrowing
in the middle portion of the stomach, however, it showed normal gastric mucosa findings.
CT andMRI revealed a large tumor extending from the region of the lower chest to the upper
abdomen. From these findings, the tumor was diagnosed as gastrointestinal stromal tumor
(GIST), which arose from the gastric wall and complicated with an esophageal hiatus her-
nia. We performed a laparotomy, however, the tumor showed severe invasion to the circum-
ferential organs. Therefore, we abandoned the excision of the tumor. Histologically, the tu-
mor was composed of spindle shaped cells withmarked nuclear atypia and prominentmitosis.
The tumor cells were strongly positive for CD34 and c-kit by immunohistochemical exami-
nation. From these findings, the tumor was definitely diagnosed as a malignant GIST. As
palliative treatment, we implanted a self-expandable metallic stent in the narrow segment
of the stomach. The patient could eat solid food and was discharged. In the treatment of
esophageal hiatus hernia, the rare association of GIST should be considered.
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CASE REPORT
An 85-year-old woman with a chief complaint of
vomiting was referred to our hospital on Decem-
ber, 22, 2000. She had complained of heartburn
after meals for the 4 months prior to admission.
She visited a local hospital, and an upper gastroin-
testianl endoscopic examination showed an esopha-
geal hiatus hernia and atrophic gastritis. She had
complained frequently of epigastralgia and appetite
loss for the 3 months prior to admission, and these
symptoms had gradually increased. She had no
history of other severe diseases. On admission, the
patient’s general condition was stable, except for
slight anemia. The heart sound was clear, and the
respiratory sound was normal. The other physical
examinations showed no abnormalities. She was
138.5 cm tall and her body weight was 36.9 kg. Her
blood pressure was 142/80 mmHg, pulse rate was
72 beats per minute and regular, although its tonus
was dull, the respiration was 13 per minute, and her
body temperature was 36.2℃. Laboratory studies
revealed : White blood cell count, 5,500 cells/mm3 ;
Hematocrit, 30.1% ;Hemoglobin, 9.8mg/dl ; Platelets
count, 22.9×104/mm3, Total protein, 6.0 g/dl ; Albu-
min, 3.4g/dl ; Total bilirubin, 0.26 mg/dl ; GOT,
20 IU/liter ; GPT, 19 IU/liter ; Alp, 279 IU/liter ; LDH,
329 IU/liter ; Choline esterase, 192 IU/liter ; Na,
141 mEq/liter, K, 4.00 mEq/liter, Cl, 104 mEq/liter ;
BUN, 19.2 mg/dl ; Creatinine, 0.57 mg/dl ; UA,
2.8 mg/dl ; Serum-amylase, 77.0 IU/liter ; Total
choresterol, 158 mg/dl ; Triglyceride, 120 mg/dl ;
Bleeding time, 1 minute ; Prothorombin activity 93% ;
APTT, 30.8 minute ; Hepplastin tast, 122.0% ; CRP,
0.13 mg/dl ; CEA, less than 0.5 mg/dl (within nor-
mal limit) ; NSE, 6.3 ng/ml (within the normal range).
An electrocardiogram showed atrial fibrillation. Re-
spiratory function, Vital capacity, 1.43 L ;%VC, 80% ;
FEV1.0%, 80.41%. A chest X-ray examination showed
no sign of a tumor or other disorders. An upper
gastrointestinal series showed a large esophageal
hiatus hernia, which also suggested an association
with extrinsic pressure in the middle portion of
the stomach (Fig. 1), however, the passage of the
contrast medium was seen to be normal from the
lower body of the stomach to the duodenum (Fig. 1).
An upper gastrointestinal endoscopic examination
showed marked flexion at the middle esophageal
portion, in which the redness of the mucosa was
marked, suggesting severe esophagitis. From the
middle to the lower portion of the body of the stom-
ach, a prominent narrowing was found, however,
no other disorders, such as erosion and ulcers were
seen in the gastric mucosa. On computed tomogra-
phy (CT), a soft tissue mass, 8 by 9 cm, was seen (Fig. 2).
This tumor was heterogenous on the contrast-enhanced
scan. On the magnetic resonance image (MRI),
the T 1-weighted image showed iso-intensity (Fig. 3A),
and the T 2-weighted image showed hyper-intensity
(Fig. 3B). The MRI image strongly suggested in-
vasion of the tumor into the aorta and the esopha-
geal hiatus (Fig. 3 A, B). Endoscopic ultrasonography
Fig. 1. Upper gastrointestinal view. Arrows show the site of extrinsic pressure in the middle portion of the stomach.
The Journal of Medical Investigation Vol. 49 2002 １８７
(7.5 Mz EUS) suggested that this tumor originated
from the wall of the stomach and extended extra-luminally.
Based on these findings, we diagnosed the tumor
as GIST, strongly suggesting malignancy. On 17,
January, 2001, a laparotomy was performed under
general anesthesia with an upper median incision
and a left oblique abdominal incision. A small amount
of bloody ascites was detected. In the intra-peritoneal
cavity and organs, there was no finding of a mass,
suggesting metastases. The tumor showed an abun-
dance of vessels, located from the anterior wall of
the upper body of the stomach to the esophageal
hiatus, extending beyond the hiatus into the posterior
mediastinum. The tumor markedly invaded the bi-
lateral curus of the diaphraguma, the retro-peritoneum,
the lesser omentum, and bled easily during the op-
erative procedures (Fig. 4). We abandened the ex-
cision of the tumor, and performed only a biopsy
for histological analysis, considering the patient’s
condition. In the histological findings of the excised
specimen with hematoxylin-eosin-staining, the tumor
contained uniform spindle cells, arranged into a
follicular growth pattern, including the foci of dense
cellularity (Fig. 5A). The mitotic response was great-
er than 10 mitotic figures per 50 HPF (Fig. 5B).
Immunohistochemical staining was negative for S100
protein (Fig. 6A) and α-SMA (Fig. 6B), but, positive
for vimentin (Fug. 6C), CD34 (Fig. 6D), and c-kit
(Fig. 6E). From these findings, the tumor was di-
agnosed as a malignant gastrointestinal stromal tu-
mor. The patient suffered post-operatively from
cardiac failure and lung congestion, and she was
treated with digitalis and gradually recovered. On
day 21 post-operatively, she was implanted with a
self expandable metallic stent (SEMS), non-covered
Ultraflex type (MicrovasiveR ; distal release system ;
Fig. 2. The findings of enhanced computed tomography.
Fig. 3. The findings of the magnetic resonant imaging. Fig. 3A is the T1-weighted image and Fig. 3B is the T2-weighted image.
Fig. 4. The laparotomy findings. Black arrows show the dis-
tal edge of the tumor arising from the anterior wall of the stom-
ach.
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length, 10 cm ; e.d., 18 mm ; i.d., 16 mm ; Boston Sci-
entific Co.) between the oral portion of the narrow
segment in the upper body of the stomach and the
anal portion (Fig. 7). After palliative treatment with
SEMS, her dysphasia significantly improved, and
she could eat solid food. The upper gastrointestinal
series showed good passage of the contrast-medium
through the implanted stent. On 23 February, 2001,
she was discharged, and could eat regular food. She
was readmitted to our hospital on 1 August, 2001,
complaining of loss of appetite and general fatigue.
An upper gastrointestinal series showed the narrowing
of SEMS, and the CT findings showed prominent
enlargement of the tumor, especially in the left up-
per abdominal cavity. A jejunostomy was performed
for tube feeding on 13 August, 2001 and she was
discharged on 22 September, 2001. She then stayed
at home with tube feeding, and was examined regu-
larly by a family doctor. Early in January, 2002, she
became markedly emaciated, and died at home on
16 February, 2002.
DISCUSSION
Gastrointestinal stromal tumors (GISTs) in the
broad sense are commonly defined as primary
mesenchymal tumors of the gastrointestine, arising
from cells located in the walls of the organ (1).
However, the pathologic evaluation of GISTs is dif-
Fig. 5. The histological findings of the specimen by hematoxylin-eosin staining. Magnification is ×100 in Fig. 5A, and ×400 in
Fig. 5B.
Fig. 6. The specimen findings of by the immunohistochemical staining. The original magnification is ×200 in each figure. The
specimen was negative for S100 protein (Fig. 6A) and α-SMA (Fig. 6B), and, positive for vimentin (Fug. 6C), CD34 (Fig. 6D), and
c-kit (Fig. 6E).
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ficult and controversial (2). Most GISTs were tra-
ditionally classified as smooth muscle tumors (2).
For the progression of the immunohistochemical
examination, it was recently demonstrated that a
large number of tumors, which had been described
as GISTs, originated from gastrointestinal autonom-
ic nerve cells (3). It was reported that several tu-
mors were differentiated as neither the smooth mus-
cle type nor the neural cell type, and GISTs of this
uncommitted type were often demonstrated to reveal
a positive reaction for CD34 (4), a myeloid progeni-
tor cell antigen presenting in endothelial cells and
some fibroblasts (4). From these findings, Rosai
divided GISTs into four major categories on the
basis of their phenotypical features : 1) Smooth mus-
cle type : Tumors showing differentiation toward the
smooth muscle cells, as evidenced immunohistochemically
by the expression of smooth muscle actin and desmin
and ultrastructually by the presence of pinocytonic
vesicles, subplasmalemnal dense patches, and
cytoplasmic microfilaments with focal densities;
2) Neural type : Tumors showing apparent differ-
entiation toward the neural elements, mainly deter-
mined by the presence on ultrastructural examina-
tion of neuron-like features such as long cytoplasmic
processes resembling axons joined by primitive
cell junctions, scattered microtubules consistent
with neurotubules, and dense-core neuro-secretary
type granules. Immunohistochemical support for
this interpretation has been meager, in the sense that
neural/neuroendocrine markers such as neurofilaments,
chromogranin, and synaptophysis have generally
been absent and the only markers in this category
showing consistently positive results have been the
less reliable neuro-specific enolase and/or S-100
proteins ; 3) Combined smooth muscle-neural type :
Tumors showing dual differentiation toward the
smooth muscle and neural elements ; 4) Uncommitted
type (GISTs in some restricted sense) : Tumors
lacking differentiation toward either cell type, even
after exhaustive immunohistochemical and ultrastructural
probing. These tumors are often positive for CD34
(1).
Interstitial cells of Cajar (ICCs), which exist in
the smooth muscle layer of the gastrointestinal tract,
have recently been considered as the pacemakers
of gastrointestinal autonomous mobility (5). In 1992,
Maeda et al. reported that only in the indigenous
gastrointestinal cells was the KIT receptor of the
c-kit gene products were demonstrated on the sur-
face of the cells, which were considered as ICCs
(6). In 1998, Hirota et al . reported that KIT recep-
tor was not found in typical smooth muscle tumors
or neural tumors, however, it was positive in 94%
of GISTs (7). Miettinen et al . previously described
that GISTs were positive for CD34 (4). Hirota et al .
described that GISTs might be derived from ICCs,
because ICCs were double-positive for CD34 and
the KIT receptor (7). Chan et al. proposed that a
definite diagnosis of GISTs should be taken by the
demonstration of the KIT receptor, which would
be a c-kit gene product. On the basis of this find-
ing, they classified gastrointestinal mesenchymal
tumors as follows : 1) GISTs which are positive for
c-kit, and many of them are also positive for CD34 ;
2) Smooth muscle tumors which are positive for
desmin, but negative for c-kit ; 3) Neural tumors,
are positive for S-100, but negative for c-kit ; 4)
Others (5). The tumor in this case was positive for
both c-kit and CD34, therefore, the definite diagno-
sis was GIST in Chan’s classification. Furthermore,
this tumor fulfilled the criteria of the uncommitted
type in Rosai’s classification.
There have been no definite criteria for the fea-
tures of clinically benign and malignant tumors. The
features purported to have prognostic importance
include tumor size, mitotic count, cellularity, nuclear
pleomorphism, cell type, and growth pattern (8).
Several studies have reported that tumor size and
mitotic counts are as important as the prognostic
Fig. 7. Upper gastrointestinal series after implantation of the
self-expandable metallic stent.
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factors (2, 8). In Ackerman’s Surgical Pathology,
GISTs were divided into three groups according to
the tumor size and mitotic rate, as follows. 1) be-
nign : mitotic count less than 5 mitotic figures per
50 high-power-field (HPF) ; 2) borderline : same
mitotic number but a tumor size large than 5 cm ;
3) malignant : mitotic count greater than 5 mitotic
figures per 50 HPF, any size tumor (1). However,
several studies suggested that the only accurate
evaluation for malignant tumors is in the evidence
of circumferential invasion and distant metastasis
(9, 10).
Few studies have been reported which described
the features of image diagnosis for GISTs. Fujiwara
et al . reported that angiography showed the abun-
dant feeding vessels of the tumor and tumor stain-
ing, plain computed tomography (CT) featured ba-
sically the iso-density tumors that sometimes include
low density areas, enhanced CT showed the increased
density that might reflect the abundance of tumor
vessels, and, T1-weighted MRI showed low inten-
sity in contrast to high intensity in T2-weighted
MRI (9).
With respect to the prognosis, Ueyama et al . re-
ported that the 10-year survival rates of patients
with gastric sarcoma or intestinal sarcoma were
74% and 17%, respectively, therefore, the sarcoma
had a more favorable prognosis when it occurred
in the stomach rather than in the intestine (2).
However, Morita et al. recently reported that any
GIST should be followed up as a potential malig-
nant tumor in the long term, because neither defi-
nite criteria nor indicators for malignant tumors have
been established (11). In this case, the intra-operative
findings showed evident invasion to the circumfer-
ential tissues, such as the diaphragm, retro-peritoneum,
and the lesser omentum, despite no evidence of
distant metastasis. According to the findings in this
case, the tumor was larger than the critical size of
5 cm and the mitotic rate was also very high. These
findings suggest that the tumor should be defined
as malignant. In addition to her advanced age, our
patient had grave cardiac complications of atrial fi-
brillation, and therefore, we considered her to be
unable to endure the aggressive surgical treatment
of thoracotomy. The findings of the laparotomy re-
vealed massive invasion and easy bleeding from
the tumor. Therefore, we had to restrict the opera-
tive procedure, and only performed an incisional
biopsy in consideration of the patient’s persever-
ance against surgical damage.
The efficacy of various prostheses has recently
been reported for palliative treatment against dysphasia
due to non-curable esophageal or stomach malignancies
(12-15). In comparison with conventional plastic
protheses, many studies have reported that this
SEMS has the advantage of easy deployment, and
thus, a high placement success rate and a low-rate
of complications, such as perforation, hemorrhage,
and pain especially during the early phase post-placement
(12-15). In addition, the great advantage of SEMS
lies in the low level of discomfort for the patient
during the stent implantation procedures (15). SEMS
consists of various types, such as Wallstent, Z stent,
and Ultraflex (14). However, it has not been con-
cluded which prothesis is the best and safest. Com-
plications were also related to design problems
with these protheses (15). Ultraflex stents of the
non-covered type was recently reported to be unable
to generate sufficient radical force for expanding
scirrhous and bulky neoplasmas (12). On the other
hand, it was reported that the non-covered type
metallic stents had a higher risk of migration of
the neoplasma than the covered type of metallic
stent (15). In this case, we obtained a definite diag-
nosis postoperatively as a malignant GIST. The pre-
operative image and the intra-operative findings
showed that the tumor originated from the stomach
wall and extended extraluminally. We expected a
low possibility of tumor invasion into the stomach
lumen, and we therefore used a non-covered Ultraflex
stent for the ease of placement, and the low possibil-
ity of displacement, and we were already accustomed
to implanting this stent.
Esophageal hiatus hernia is a common disorder
in the upper gastro-intestinal organs, and is often
found, especially in elderly women. Kawai et al . re-
cently reported cases of the upside-down type of
esophageal hiatus hernia, which were complicated
with gastric cancer (16). They also suggested the
difficulty of correctly diagnosing a malignant tumor
when the stomach is herniated to the mediastinum
in the esophageal hiatus hernia, because the precise
diagnosis is distorted even though various image
techniques are used (16). This case had the sliding
type of hernia, but not the upside-down type. It is
suggested that the early detection of GIST in the
stomach is faciliated using images, such as an upper
gastro-intestinal series and upper gastrointestinal
endoscopy when the tumor extends into the gastric
lumen. Furthermore, the tumor symptoms might
appear during an earlier stage. In this case, the
extra-luminal extension of the GIST may have de-
layed the appearance of the stenosis, thus delay-
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ing the definite diagnosis.
In conclusion, we should consider the rare asso-
ciation of GIST when a patient is examined and the
condition is clinically diagnosed as esophageal hia-
tus. For palliative treatment against non-resectable
GIST, the implantation of a self-expandable metallic
stent, Ultraflex, was useful to improve the patient’s
quality of life in this case.
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